Page 1,708«..1020..1,7071,7081,7091,710..1,7201,730..»

Annual Summit on Cell Therapy and Molecular Medicine …

Posted: Published on June 13th, 2017

Sessions/Tracks Track 1: Cell Therapy Cell therapy or cytotherapy is the transfer of cells into a patient with a goal of improving the disease. From beginning blood transfusions were considered to be the first type of cell therapy to be practised as routine. Later, Bone marrow transplantation has also become a well established concept which involves treatment of many kind of blood disorders including anemia, leukemia, lymphyoma and rare immunodeficiency diseases. Alternative medical practitioners perform cell therapy in the form of several different names including xenotransplant therapy, glandular therapy, and fresh cell therapy. It has been claimed by the proponents of cell therapy that it has been used successfully to repair spinal cord injuries, strengthen weaken immune system, treats autoimmune diseases like AIDS, help patients with neurological disorders like Alzheimers disease, parkinsons disease and epilepsy. Related Conferences 3rd International Conference & Exhibition on Tissue Preservation and Biobanking, Aug 23-24 2017, San Francisco, USA; Annual Summit onCell Signalingand Cancer Therapy, Sep 27-28, 2017, Chicago, USA; 8th World Congress and Expo on Cell & Stem Cell Research, March 20-22, 2017 in Orlando, Florida, USA; Annual Summit on Cell Therapyand Molecular Medicine, Sep 27-28, 2017, Chicago, USA; 2nd World Biotechnology Congress, Dec 4-5 … Continue reading

Posted in Cell Therapy | Comments Off on Annual Summit on Cell Therapy and Molecular Medicine …

For experimental cancer therapy, a struggle to ensure supply keeps up with demand – Science Magazine

Posted: Published on June 13th, 2017

The year-old Novartis-Penn Center for Advanced Cellular Therapeutics in Philadelphia supplies cancer fighting T cells to multiple hospitals, visible out the window. CANNONDESIGN By Jennifer Couzin-FrankelJun. 13, 2017 , 3:15 PM A transformative cancer therapy based on modified immune cells has lured doctors, companies, and patients alike, but many are hitting a frustrating roadblock: generating enough of these chimeric antigen receptor (CAR)-T cells to meet surging demand. The situation is fluid, with shortages cropping up in some places and easing in others. Doctors, meanwhile, are grappling with how best to distribute the experimental therapy among very sick patients in clinical trials. How do I allocate the resource in a way thats fairest to everybody and that treats the most patients and potentially saves the most lives? asks Stephan Grupp, a pediatric oncologist at the Childrens Hospital of Philadelphia (CHOP) in Pennsylvania. Grupp has offered CAR-T therapy to more than 150 children with late-stage acute lymphoblastic leukemia (ALL)and worries that because of supply limitations, he cant help more. CAR-T cell therapy took the cancer world by storm in the summer of 2010. It involves removing a patients immune cells, genetically modifying them to fight their particular cancer, then transfusing them back. … Continue reading

Posted in Cell Therapy | Comments Off on For experimental cancer therapy, a struggle to ensure supply keeps up with demand – Science Magazine

Texas is leading the charge on stem cell therapy – ThinkProgress

Posted: Published on June 13th, 2017

In the last weeks of the legislative session, Texas lawmakers passed a historic bill that legalizes investigative stem cell treatments for chronically ill patients. Despite the prevalence of unregulated stem cell clinics in the United States, this could be the first time a state has authorized the treatment for chronic illnesses, if the states governor approves the legislation. Youre watching an episode of In Session, a weekly series exploring interesting policy changes on the state level. PHOEBE GAVIN, ThinkProgress: Youll never guess which state is on track to become the first to recognize stem cell therapy as a treatment for chronic illnesses. Ill give you a hint: its former governor and our former president once banned federal funding for research on embryonic stem cells You guessed it: Its The Lone Star State! In the last week of its legislative session, Texas lawmakers approved a bill that legalizes Investigational Stem Cell Treatment, which basically means treatments that have been evaluated by an institutional review board but have not yet been approved by the FDA. Keep in mind, though: this isnt about embryonic stem cells. The cells will come from banked umbilical cords and the patients themselves, who will be allowed to … Continue reading

Posted in Cell Therapy | Comments Off on Texas is leading the charge on stem cell therapy – ThinkProgress

Heart House Cardiology Brings New Doctor On Board – Benzinga

Posted: Published on June 13th, 2017

Dr. Jason Palermo joins the southern New Jersey healthcare group. Haddon Heights, N.J. (PRWEB) June 13, 2017 Dr. Jason Palermo, a Board-certified cardiologist with over 14 years of experience, has joined the staff of The Heart House, a cardiology group with six offices throughout Southern New Jersey. Dr. Palermo, who specializes in non-invasive cardiology, is a proponent of nutrition, weight management and exercise to stave off heart disease. He is also an adjunct professor in Rowan University's Health and Exercise Science Department. Prior to joining The Heart House, formerly known as Cardiovascular Associates of the Delaware Valley, Dr. Palermo practiced with Virtua Cardiology Group in Voorhees, N.J. From 2009 to 2011, he was part of Cardiology Consultants of Delaware, in Lewes, Delaware. Born and raised in South Jersey, Dr. Palermo earned a bachelor of science degree from Richard Stockton College of New Jersey (now Stockton University), and in 2003 received his medical degree from Temple University School of Medicine. After medical school, he completed his Internal Medicine Residency and Cardiovascular Disease Fellowship at Temple. He is certified in Cardiovascular Disease, Internal Medicine, and Nuclear Cardiology. In 2013, Dr. Palermo was selected as a "Top Doc," Cardiovascular Disease, by SJ Magazine. … Continue reading

Posted in Cardiology | Comments Off on Heart House Cardiology Brings New Doctor On Board – Benzinga

Biotechnology FAQs | USDA

Posted: Published on June 13th, 2017

1. What is Agricultural Biotechnology? Agricultural biotechnology is a range of tools, including traditional breeding techniques, that alter living organisms, or parts of organisms, to make or modify products; improve plants or animals; or develop microorganisms for specific agricultural uses. Modern biotechnology today includes the tools of genetic engineering. 2. How is Agricultural Biotechnology being used? Biotechnology provides farmers with tools that can make production cheaper and more manageable. For example, some biotechnology crops can be engineered to tolerate specific herbicides, which make weed control simpler and more efficient. Other crops have been engineered to be resistant to specific plant diseases and insect pests, which can make pest control more reliable and effective, and/or can decrease the use of synthetic pesticides. These crop production options can help countries keep pace with demands for food while reducing production costs. A number of biotechnology-derived crops that have been deregulated by the USDA and reviewed for food safety by the Food and Drug Administration (FDA) and/or the Environmental Protection Agency (EPA) have been adopted by growers. Many other types of crops are now in the research and development stages. While it is not possible to know exactly which will come to fruition, certainly … Continue reading

Posted in Biotechnology | Comments Off on Biotechnology FAQs | USDA

iShares Nasdaq Biotechnology Index Fund (IBB) Shares Sold by Neumann Capital Management LLC – The Cerbat Gem

Posted: Published on June 13th, 2017

iShares Nasdaq Biotechnology Index Fund (IBB) Shares Sold by Neumann Capital Management LLC The Cerbat Gem iShares Nasdaq Biotechnology Index Fund logo Neumann Capital Management LLC lowered its position in shares of iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) by 44.8% during the first quarter, according to its most recent Form 13F filing with ... The iShares NASDAQ Biotechnology Index (IBB) Position Boosted by Stratos Wealth Partners LTD.BangaloreWeekly Glassman Wealth Services Has $352000 Position in iShares Nasdaq Biotechnology Index Fund (IBB)Chaffey Breeze iShares Nasdaq Biotechnology Index Fund (IBB) Stake Raised by Private Management Group Inc.Stock Observer all 10 news articles » The rest is here: iShares Nasdaq Biotechnology Index Fund (IBB) Shares Sold by Neumann Capital Management LLC - The Cerbat Gem … Continue reading

Posted in Biotechnology | Comments Off on iShares Nasdaq Biotechnology Index Fund (IBB) Shares Sold by Neumann Capital Management LLC – The Cerbat Gem

Biology A-level students mark down exam board after yet another error – The Guardian

Posted: Published on June 13th, 2017

Almost 19,000 students sat the OCR biology A-level paper on Monday that contained an error. Photograph: Chris Radburn/PA One of Englands main examination boards has been forced to issue an apology for the third time in a little over a fortnight after students and teachers spotted yet another error on one of its papers. The mistake occurred on OCRs A-level biology paper, which was sat by almost 19,000 students on Monday. A question asked students to calculate a standard deviation but failed to provide the formula needed for the calculation, as required by the syllabus. Pupils took to student forums and social media to express their anger about the error and worries about the possible impact on their overall grade. OCR apologised and said it would address any impact during marking and grading. Exam watchdog Ofqual was also notified about an error in an AQA chemistry A-level, which 20,000 students took on Tuesday. A two-mark question included an incorrect equation, in which a 3 was printed instead of a 2, which made it unanswerable. A spokesman for Ofqual said: We expect all papers to be error-free. When errors are not identified before the exam, we expect the exam boards to … Continue reading

Posted in Biology | Comments Off on Biology A-level students mark down exam board after yet another error – The Guardian

‘Exciting biology’ uncovers plants’ high-fat diet for fungal benefactors – Phys.Org

Posted: Published on June 13th, 2017

June 13, 2017 One of biology's most enduring relationships, credited with helping plants to colonise land more than 400 million years ago, has yielded a fundamental survival secret with implications for agriculture and biotechnology. Plant scientists have discovered that a particular form of fungi, which invades plant roots and then helps the colonised plants to absorb nutrients from soil, receive life-sustaining carbon from their symbiotic hosts in the form of long-chain fatty acids, a building block for essential lipids. Previously, scientists had thought that the fungi received carbon from their hosts only in the form of carbohydrates, which the fungi used to make their own fatty acids and then the more complex lipids necessary for survival. It's now clear that the main source of carbon from the host plants are fatty acids, and that these fatty acids are necessary before the fungi can create the more complex lipids that are needed for storing energy, for signalling and for cellular membranes. The latest work, published by the journal Science, comes from a joint team of scientists from the John Innes Centre, based at Norwich Research Park, and Rothamsted Research. This field of science is very competitive currently, with research groups in … Continue reading

Posted in Biology | Comments Off on ‘Exciting biology’ uncovers plants’ high-fat diet for fungal benefactors – Phys.Org

Leaving Cert biology: Incinerator and IVF on lively paper – Irish Times

Posted: Published on June 13th, 2017

Topical questions included the incinerator at Poolbeg. Photograph: Brenda Fitzsimons This years higher-level Leaving Cert biology paper was particularly topical and challenging, though it was not unfair, according to teachers. Students would have enjoyed the experiment questions on this afternoons paper but it was not without its harder sections, said Luke Saunders, founder of Studyclix.ie and a biology teacher at Jesus and Mary Secondary School in Enniscrone. Students who had prepared using past exams wouldnt have found much to shock them. The popular topic of ecology featured heavily throughout which would have brought smiles to many students because it allowed them to make lots of references to one of the more practical areas of the course. Ciara OShea, ASTI subject representative and deputy principal at Scoil Mhuire agus Padraig in Swinford, Co Mayo, said the paper rewarded students who had put the work in. There was nothing too tricky and there were questions from right across the syllabus. It was particularly good to see topical questions on the paper, including the incinerator at Poolbeg, the Zika virus and IVF. More of this would be welcome in future years. Mona Murray a biology teacher at the Institute of Education in Dublin, … Continue reading

Posted in Biology | Comments Off on Leaving Cert biology: Incinerator and IVF on lively paper – Irish Times

The Exquisite Design of Human Biology – Discovery Institute

Posted: Published on June 13th, 2017

There is a certain characteristic shallowness to the storytelling exercise that is evolutionary biology. Evolutionists spin a narrative about lifes history, about events that no one can or ever will witness. Theyre trying to explain how complex, functional living systems come into existence, and the imaginative tale-telling gets them out of having to grapple with what it takes, practically, for any complex living being to fight the battle of staying alive in the first place. Evolutionists dont worry much about how living things work, the irreducible complexity of it, or how other complex systems work, either. For insights on function you have to go to physicians and engineers. Thats a point underlying much of the writing done by two of our contributors, Steve Laufmann and Dr. Howard Glicksman. In a new ID the Future podcast with interviewer Todd Butterfield, Laufmann reflects on the evidence of design in the human body, presented in Dr. Glicksmans series, The Designed Body. Listen to the podcast here, or download it here. Laufmanns specialty is the architecture of very large, very complex, composite information systems that are orchestrated to perform specified tasks in demanding environments. He looks at biology from an engineers perspective, which is … Continue reading

Posted in Biology | Comments Off on The Exquisite Design of Human Biology – Discovery Institute

Page 1,708«..1020..1,7071,7081,7091,710..1,7201,730..»